Physical Inactivity and the Economic and Health Burdens Due to Cardiovascular Disease: Exercise as Medicine

Mark Hamer, Gary Adamson, MH Murphy

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Leisure time physical activity, or exercise, has been described as today’s best buy in public health. Physical inactivity is responsible for around 10% of all deaths and physical inactivity costs global healthcare systems billions of dollars each year. Here, we describe the human and economic costs of cardiovascular disease. Then, we explain that physical inactivity is a major modifiable risk factor for cardiovascular disease. The evidence of the role of physical activity in the primary prevention of cardiovascular disease is reviewed and we make the case that exercise is medicine.
Original languageEnglish
Title of host publicationExercise for Cardiovascular Disease Prevention and Treatment. Advances in Experimental Medicine and Biology
Place of PublicationSingapore
PublisherSpringer
Pages3-18
Volume999
ISBN (Print)978-981-10-4307-9
Publication statusE-pub ahead of print - 20 Oct 2017

Keywords

  • physical activity

Fingerprint Dive into the research topics of 'Physical Inactivity and the Economic and Health Burdens Due to Cardiovascular Disease: Exercise as Medicine'. Together they form a unique fingerprint.

  • Cite this

    Hamer, M., Adamson, G., & Murphy, MH. (2017). Physical Inactivity and the Economic and Health Burdens Due to Cardiovascular Disease: Exercise as Medicine. In Exercise for Cardiovascular Disease Prevention and Treatment. Advances in Experimental Medicine and Biology (Vol. 999, pp. 3-18). Springer. http://uir.ulster.ac.uk/38896/1/Springer%20Book%20chapter_Hamer%20et%20al.docx